Lunxu Liu

Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer

Wenhua Liang, Li Zhang, Gening Jiang et al. · Journal of Clinical Oncology · 2015 · 690 citations · Full text

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 520 citations

Medicine, Pathology, Gefitinib Versus Vinorelbine +8

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

Wenhua Liang, Jiaxi He, Yaxing Shen et al. · Journal of Clinical Oncology · 2017 · 353 citations · Full text

Surgical Oncology, Epidemiology Of Cancer, Threshold Eln Count +18

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · Journal of Clinical Oncology · 2020 · 261 citations · Full text

Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer

Yong Peng, Yuntao Dai, Charles L. Hitchcock et al. · Proceedings of the National Academy of Sciences · 2013 · 156 citations · Full text